Celularity, Inc. (CELU)
1.31
-0.04
(-2.97%)
USD |
NASDAQ |
Feb 23, 15:20
Celularity Total Assets (Quarterly) : 114.24M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 3.646B |
| Organogenesis Holdings, Inc. | 509.83M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 134.33M |
| Shareholders Equity (Quarterly) | -20.09M |
| Debt to Equity Ratio | -3.322 |
| Current Ratio | 0.1622 |
| Net Debt Paydown Yield | 0.20% |